Table 2.
Analytes | Difference in value compared to the deuterated analog [%] | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
tetracosane | BPO | DEDF | H‐d 8 | G‐d 8 | S‐d 8 | G‐pBA‐d 8 | S‐pBA‐d 8 | G‐DD pCA‐d 10 | S‐DD pCA‐d 10 | G‐DDFA‐d 10 | S‐DDFA‐d 10 | |
H‐OH/Ac | 30 | 47 | 43 | 0 | 2 | 2 | 17 | 40 | 22 | 26 | 24 | 56 |
G‐OH/Ac | 35 | 41 | 145 | 4 | 0 | 4 | 91 | 146 | 95 | 124 | 141 | 158 |
S‐OH/Ac | 31 | 45 | 124 | 4 | 2 | 0 | 63 | 102 | 73 | 88 | 98 | 114 |
G‐pBA | 3517 | 4580 | 54 | 29 | 14 | 19 | 0 | 43 | 15 | 17 | 3 | 62 |
S‐pBA | 53 | 60 | 64 | 50 | 37 | 41 | 30 | 0 | 40 | 18 | 32 | 13 |
G‐DHpCA | 308 | 308 | 9 | 44 | 50 | 47 | 27 | 34 | 0 | 17 | 6 | 46 |
S‐DHpCA | 11 | 25 | 7 | 25 | 35 | 32 | 9 | 14 | 14 | 0 | 9 | 24 |
G‐DHFA | 2123 | 2378 | 39 | 26 | 4 | 2 | 4 | 47 | 12 | 20 | 0 | 66 |
S‐DHFA | 2133 | 2351 | 4 | 12 | 71 | 67 | 17 | 11 | 36 | 24 | 30 | 0 |
[a] ▪=deuterated analogue, ▪=<10 %, ▪=10–25 %, ▪=25–50 %, ▪=>50 % difference.